Rowsley can raise value by divesting non-core assets
IF BILLIONAIRE Peter Lim had wanted to realise the fullest value for the Thomson Medical healthcare group, an initial public offering (IPO) would have been the cleanest way to structure a deal.
By choosing instead to inject these healthcare assets into Rowsley, the listed firm which he also controls, Mr Lim seems to be making an effort to reverse the fortunes of the loss-making company with interests in a mishmash of businesses including real estate, design consultancy and hotel management.
On Monday, Rowsley inked a deal to acquire the Thomson Medical's businesses from Mr Lim for S$1.6 billion, to be paid mostly in stock. An IPO was certainly something Thomson had considered. In September last year, Roy Quek, executive chairman of Thomson Medical and chief executive of TMC Life Sciences, told The Business Times that the group was gunning for an initial public offering. He told BT then: "If we were to do a listing now, we'd probably have a market capitalisation of S$2 billion to S$3 billion. I think we can do better. We're targeting S$5 billion for a start and trying to grow that."
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
ETF popularity poised to stay as investors flock to diversification, stability
Interests of OCBC and Great Eastern’s minority shareholders are fundamentally misaligned
Aims Apac Reit posts 10.2% lower H2 DPU on enlarged unit base
VinFast’s EV ambitions get a reality check as shares plunge 65%
Stocks to watch: FLCT, Paragon Reit, AA Reit, Lendlease Global Reit, Far East Orchard, SIA
Jefferies asks judge to remove managers of Weiss Multi-Strategy